Clinical trial
Assessment of Revascularization Effects in Peripheral Arterial Disease Using Contrast Ultrasound Tissue Perfusion Imaging (REVASC-PI)
NCT00424450 is registered in ClinicalTrials.gov with University Hospital Freiburg as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Assessment of Revascularization Effects in Peripheral Arterial Disease Using Contrast Ultrasound Tissue Perfusion Imaging (REVASC-PI)
- Lead sponsor
- University Hospital Freiburg
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 31, 2006
- Completion date
- July 31, 2009
- Enrollment
- 30 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.